Skip to content

Screening of tumor markers for digestive cancer based on metabolomics

Screening of tumor markers for digestive cancer based on metabolomics

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022425
Enrollment
Unknown
Registered
2019-04-10
Start date
2019-03-28
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive cancer

Interventions

Gold Standard:Pathological examination
tumor&#32

Sponsors

The First Affiliated hospital of NanChang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Male or female, aged = 18; (2) the subject reads and fully understands the instructions of the patient, and signs the informed consent; (3) the normal control group was the healthy population examined by the physical examination center or the patients pathologically diagnosed as non-malignant tumors; (4) newly diagnosed patients with esophageal cancer, gastric cancer, colon cancer, rectal cancer and colon polyp were not treated with any anti-tumor therapy.

Exclusion criteria

Exclusion criteria: (1) patients with other malignant tumors; (2) patients with severe metabolic diseases; (3) emergency treatment or patient rescue; (4) pregnancy.

Design outcomes

Primary

MeasureTime frame
Tumor biomakers;

Countries

China

Contacts

Public ContactChen Youxiang

The First Affiliated Hospital of NanChang University

chenyx102@126.com+86 13879169980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026